American Century Companies Inc Bio Techne Corp Transaction History

American Century Companies Inc

$156 Billion
Q1 2024

A detailed history of American Century Companies Inc transactions in Bio Techne Corp stock. As of the latest transaction made, American Century Companies Inc holds 1,409,931 shares of TECH stock, worth $109 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,409,931

Previous 1,409,323 0.04%

Holding current value

$109 Million

Previous $109 Million 8.73%

% of portfolio

0.06%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $40,115 - $46,870	608 Added 0.04%	1,409,931 $99.2 Million
Q4 2023 Feb 13, 2024	BUY	$52.83 - $78.22 $74.5 Million - $110 Million	1,409,323 New	1,409,323 $109 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $2.42 Million - $3.2 Million	-35,776 Reduced 2.44%	1,429,601 $97.3 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $9.89 Million - $11.5 Million	134,127 Added 10.08%	1,465,377 $120 Million
Q1 2023 May 11, 2023	BUY	$71.62 - $86.62 $1.5 Million - $1.82 Million	20,970 Added 1.6%	1,331,250 $98.8 Million

Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $79.8 Million - $349 Million	989,738 Added 308.77%	1,310,280 $109 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $1.73 Million - $2.4 Million	-6,117 Reduced 1.87%	320,542 $91 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $3.52 Million - $4.9 Million	-10,897 Reduced 3.23%	326,659 $113 Million
Q1 2022 May 11, 2022	SELL	$353.85 - $487.79 $9.31 Million - $12.8 Million	-26,304 Reduced 7.23%	337,556 $146 Million
Q4 2021 Feb 07, 2022	BUY	$456.15 - $525.06 $287,830 - $331,312	631 Added 0.17%	363,860 $188 Million
Q3 2021 Nov 10, 2021	BUY	$444.87 - $538.88 $4.32 Million - $5.24 Million	9,715 Added 2.75%	363,229 $176 Million
Q2 2021 Aug 05, 2021	BUY	$387.35 - $450.26 $5.72 Million - $6.65 Million	14,778 Added 4.36%	353,514 $159 Million
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $62.4 Million - $81.5 Million	198,258 Added 141.13%	338,736 $129 Million
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $123,943 - $161,578	-502 Reduced 0.36%	140,478 $44.6 Million
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $367,139 - $447,359	-1,581 Reduced 1.11%	140,980 $34.9 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $2.3 Million - $3.47 Million	-12,405 Reduced 8.0%	142,561 $37.6 Million
Q1 2020 May 14, 2020	SELL	$161.17 - $221.51 $574,409 - $789,461	-3,564 Reduced 2.25%	154,966 $29.4 Million
Q4 2019 Feb 12, 2020	SELL	$189.68 - $222.09 $8.63 Million - $10.1 Million	-45,480 Reduced 22.29%	158,530 $34.8 Million
Q3 2019 Nov 13, 2019	SELL	$183.56 - $216.72 $3.16 Million - $3.73 Million	-17,213 Reduced 7.78%	204,010 $39.9 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $5.8 Million - $6.62 Million	30,746 Added 16.14%	221,223 $46.1 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $4.56 Million - $6.72 Million	33,512 Added 21.35%	190,477 $0
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $16 Million - $24.6 Million	120,557 Added 331.13%	156,965 $22.7 Million
Q3 2018 Nov 02, 2018	SELL	$147.44 - $204.11 $55.2 Million - $76.4 Million	-374,486 Reduced 91.14%	36,408 $7.43 Million
Q2 2018 Aug 08, 2018	BUY	$144.9 - $165.58 $270,383 - $308,972	1,866 Added 0.46%	410,894 $60.8 Million
Q1 2018 May 03, 2018	SELL	$131.46 - $151.04 $1.57 Million - $1.81 Million	-11,961 Reduced 2.84%	409,028 $61.8 Million
Q4 2017 Feb 02, 2018	SELL	$121.17 - $134.75 $16.4 Million - $18.2 Million	-135,412 Reduced 24.34%	420,989 $54.5 Million
Q3 2017 Nov 01, 2017	BUY	$113.59 - $123.78 $63.2 Million - $68.9 Million	556,401	556,401 $67.3 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.03B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Bio Techne Corp Transaction History